Does LENVATINIB Cause Malignant pleural effusion? 28 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 28 reports of Malignant pleural effusion have been filed in association with LENVATINIB (Lenvima). This represents 0.1% of all adverse event reports for LENVATINIB.
28
Reports of Malignant pleural effusion with LENVATINIB
0.1%
of all LENVATINIB reports
11
Deaths
23
Hospitalizations
How Dangerous Is Malignant pleural effusion From LENVATINIB?
Of the 28 reports, 11 (39.3%) resulted in death, 23 (82.1%) required hospitalization, and 4 (14.3%) were considered life-threatening.
Is Malignant pleural effusion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LENVATINIB. However, 28 reports have been filed with the FAERS database.
What Other Side Effects Does LENVATINIB Cause?
Diarrhoea (4,262)
Hypertension (4,152)
Fatigue (3,603)
Decreased appetite (3,257)
Malignant neoplasm progression (2,929)
Nausea (2,492)
Blood pressure increased (2,228)
Vomiting (1,962)
Asthenia (1,643)
Malaise (1,602)
What Other Drugs Cause Malignant pleural effusion?
PEMBROLIZUMAB (97)
CARBOPLATIN (65)
BEVACIZUMAB (64)
LETROZOLE (63)
NIVOLUMAB (61)
FULVESTRANT (58)
PACLITAXEL (58)
PALBOCICLIB (55)
CYCLOPHOSPHAMIDE (49)
OSIMERTINIB (46)
Which LENVATINIB Alternatives Have Lower Malignant pleural effusion Risk?
LENVATINIB vs LEPONEX
LENVATINIB vs LERCANIDIPINE
LENVATINIB vs LETAIRIS
LENVATINIB vs LETERMOVIR
LENVATINIB vs LETROZOLE